Indian pharmaceutical sector

The Pharmaceutical Sector in India India is emerging as one of the largest and cheapest producers of therapeutics in the world, accounting in volume for nearly 8.5% of the world s drug requirements. The Indian pharmaceutical sector has achieved global recognition as a low-cost producer of bulk chemicals and formulation products. 

Srinivas, S. (2004) Technological Learning and the Evolution of the Indian Pharmaceutical and Biopharmaceutical Sectors, Unpublished Dissertation, Massachusetts Institute of Technology, Cambridge, MA. 

In India, many global pharmaceutical players (Pfizer, Novartis, AstraZeneca, Eli Lilly, GSK, Aventis, Novo Nordisk, Bristol-Myers Squibb, Roche and Amgen - to name but a few) have expanded their existing clinical research investment and infrastmcture Table VI). According to estimates from Chiltem International, in 2005, outsourced clinical trials generated an estimated 71 million in revenues for Indian companies in this sector, and were predicted to grow to 318 million by 2010. 

---